SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.

Charles M Rudin Stephen V Liu Ross Andrew Soo Shun Lu Min Hee HongJong-Seok LeeMaciej BrylDaphne W Dumoulin Achim Rittmeyer Chao-Hua ChiuOzgur OzyilkanMelissa Lynne JohnsonAlejandro NavarroSilvia Novello Yuichi OzawaSammi Hiu TamNamrata S PatilXiaohui WenMeilin HuangTien HoangRaymond MengMartin Reck

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

Tiragolumab did not provide additional benefit over atezolizumab and CE in untreated ES-SCLC. The combination was well tolerated with no new safety signals.

Keyphrases

small cell lung cancer
locally advanced
brain metastases
squamous cell carcinoma
radiation therapy
rectal cancer
energy transfer
quantum dots